Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 79, 472-480
Abstract
No abstract availableKeywords
Funding Information
- King Saud University (RGP-120)
This publication has 46 references indexed in Scilit:
- Imbalance between the anti- and pro-inflammatory milieu in blood leukocytes of autistic childrenMolecular Immunology, 2017
- STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritisImmunobiology, 2017
- Resveratrol treatment attenuates chemokine receptor expression in the BTBR T + tf/J mouse model of autismMolecular and Cellular Neuroscience, 2016
- The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3+ regulatory T cells during pathogenesis of rheumatoid arthritisMolecular Immunology, 2016
- Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autismMolecular Neurobiology, 2016
- Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic childrenJournal of Neuroinflammation, 2013
- Maternal immune activation by poly(I:C) induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brainJournal of Neuroinflammation, 2012
- Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disordersThe World Journal of Biological Psychiatry, 2011
- The Current STATus of lymphocyte signaling: new roles for old playersCurrent Opinion in Immunology, 2009
- The immune response in autism: a new frontier for autism researchJournal of Leukocyte Biology, 2006